A new treatment for multiple sclerosis (MS) has demonstrated good safety and tolerability in a phase 1b study published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results